Exact Sciences (company)

Exact Sciences (company)

Exact Sciences is a Madison, Wisconsin-based biotechnology company focused on developing and manufacturing non-invasive screening tests for the early detection of cancer.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Post-IPO Debt
850,000,000
February 24, 2020
174,000,000
July 24, 2015
8,200,000
June 15, 2009
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Ali Malihi

Investor

Amit Patel

Investor

Andrew Packer

Employee

Antony Salvi

Employee

Ben Frodl

Employee

Camden Moore

Employee

CElda BOrchardt

Employee

Charles Hackworthy

Employee

Dan Donovan

Employee

Douglas Fennig

Employee

Gabriel Lee, PMI-ACP

Investor

Hemanth D. Shenoi, Ph.D.

Employee

Jamison Vaughn

Employee

Jesse Lucas

Employee

Jill Blanchard

Employee

Joshua Haase

Employee

Karen Ostrov

Investor

KATIE SWEENEY

Employee

Lucas Gaffney

Employee

Megan Reiss

Employee

Megan Rothney

Employee

MIchael Matter

Employee

Michael Welch

Employee

Noah Turecek

Employee

Richard Sneider

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
EXACT SCIENCES CORP
February 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited...
EXACT SCIENCES CORP
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close...
EXACT SCIENCES CORP
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors...
EXACT SCIENCES CORP
January 13, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology...
EXACT SCIENCES CORP
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for...
EXACT SCIENCES CORP
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for...
EXACT SCIENCES CORP
December 28, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- Today Stand Up To Cancer® (SU2C) unveiled a collaborative initiative aimed at improving colorectal cancer screening, early detection and...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire-HISPANIC PR WIRE/ -- Hoy Unidos Contra El Cáncer® (Stand Up To Cancer, SU2C) dio a conocer una iniciativa de colaboración destinada a mejorar los...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire-HISPANIC PR WIRE/ -- Today Stand Up To Cancer® (SU2C) unveiled a collaborative initiative aimed at improving colorectal cancer screening, early...
EXACT SCIENCES CORP
December 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the presentation of new data at the virtual 2020 San Antonio Breast Cancer Symposium...
EXACT SCIENCES CORP
November 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.